Maternal Alcohol Use and the Neonate




27.

Bakhireva LN, Savich RD, Raisch DW, Cano S, Annett RD, Leeman L, et al. The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots. Alcohol Clin Exp Res. 2013;37(6):1008–15. PMCID: 3661684.PubMed


28.

Abel EL, Sokol RJ. A revised conservative estimate of the incidence of FAS and its economic impact. Alcohol Clin Exp Res. 1991;15(3):514–24.PubMed


29.

Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973;302(7836):999–1001.PubMed


30.

Little BB, Snell LM, Rosenfeld CR, Gilstrap 3rd LC, Gant NF. Failure to recognize fetal alcohol syndrome in newborn infants. Am J Dis Child. 1990;144(10):1142–6.PubMed


31.

Mattson SN, Riley EP, Gramling L, Delis DC, Jones KL. Heavy prenatal alcohol exposure with or without physical features of fetal alcohol syndrome leads to IQ deficits. J Pediatr. 1997;131(5):718–21.PubMed


32.

O’Leary CM, Jacoby PJ, Bartu A, D’Antoine H, Bower C. Maternal alcohol use and sudden infant death syndrome and infant mortality excluding SIDS. Pediatrics. 2013;131(3):e770–8.PubMed


33.

Sokol RJ, Janisse JJ, Louis JM, Bailey BN, Ager J, Jacobson SW, et al. Extreme prematurity: an alcohol-related birth effect. Alcohol Clin Exp Res. 2007;31(6):1031–7.PubMed


34.

Martinelli P, Sarno L, Maruotti GM, Paludetto R. Chorioamnionitis and prematurity: a critical review. J Matern Fetal Neonatal Med. 2012;25 Suppl 4:29–31.PubMed


35.

Aly H, Alhabashi G, Hammad TA, Owusu-Ansah S, Bathgate S, Mohamed M. ABO phenotype and other risk factors associated with chorioamnionitis. J Pediatr. 2008;153(1):16–8.PubMed


36.

Rickert VI, Wiemann CM, Hankins GD, McKee JM, Berenson AB. Prevalence and risk factors of chorioamnionitis among adolescents. Obstet Gynecol. 1998;92(2):254–7.PubMed


37.

Han CS, Schatz F, Lockwood CJ. Abruption-associated prematurity. Clin Perinatol. 2011;38(3):407–21. PMCID: 3175371.PubMed


38.

Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand. 2006;85(6):700–5.PubMed


39.

Hardy G, Benjamin A, Abenhaim HA. Effect of induced abortions on early preterm births and adverse perinatal outcomes. J Obstet Gynaecol Can. 2013;35(2):138–43.PubMed


40.

Henriet L, Kaminski M. Impact of induced abortions on subsequent pregnancy outcome: the 1995 French national perinatal survey. BJOG. 2001;108(10):1036–42.PubMed


41.

Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–56. PMCID: 2982806.PubMed


42.

Alarcon A, Pena P, Salas S, Sancha M, Omenaca F. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J. 2004;23(4):295–9.PubMed


43.

Cordero L, Rau R, Taylor D, Ayers LW. Enteric gram-negative bacilli bloodstream infections: 17 years’ experience in a neonatal intensive care unit. Am J Infect Control. 2004;32(4):189–95.PubMed


44.

Benjamin Jr DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117(1):84–92.PubMed


45.

Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285–91.PubMed


46.

Stoll BJ, Holman RC, Schuchat A. Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics. 1998;102(2):e18.PubMed


47.

Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis. 2006;19(3):290–7.PubMed


48.

Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. Jama. 2004;292(19):2357–65.PubMed


49.

Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98.PubMed


50.

From the American Academy of Pediatrics. Policy statements—modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124(6):1694–701.


51.

Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232–9.PubMed


52.

Louie JK, Schechter R, Honarmand S, Guevara HF, Shoemaker TR, Madrigal NY, et al. Severe pediatric influenza in California, 2003–2005: implications for immunization recommendations. Pediatrics. 2006;117(4):e610–8.PubMed


53.

Johnson S, Knight R, Marmer DJ, Steele RW. Immune deficiency in fetal alcohol syndrome. Pediatr Res. 1981;15(6):908–11.PubMed


54.

Wang X, Ho WZ. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci. 2011;88(21–22):972–9. PMCID: 3100448.PubMed


55.

Gauthier TW, Manar MH, Brown LAS. Is maternal alcohol use a risk factor for early-onset sepsis in the premature newborn? Alcohol. 2004;33:139–45.PubMed


56.

Bustani P, Kotecha S. Role of cytokines in hyperoxia mediated inflammation in the developing lung. Front Biosci. 2003;8:s694–704.PubMed


57.

De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr. 2001;160(8):457–63.PubMed

Sep 18, 2016 | Posted by in CARDIOLOGY | Comments Off on Maternal Alcohol Use and the Neonate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access